201 Followers on Owler

Q32 Bio

is a Massachusetts-based clinical-stage biotechnology company that researches and develops novel therapeutics for the treatment of immune diseases... Read more
OverviewCompetitorsFundingNews & Insights

Q32 Bio

is a Massachusetts-based clinical-stage biotechnology company that researches and develops novel therapeutics for the treatment of immune diseases... Read more
Q32 Bio CEO: Jodie P. Morrison

CEO

Jodie P. Morrison

CEO Approval Rating

86/100

2017

PublicMerged with Homology Medicines, Inc.NASDAQQTTB

Pharmaceuticals & Biotechnology
Biotechnology

Annual Revenue
<$1M
Employees
39
Funding
$157M

News

Conference Presentation
Feb 05, 2025
PR Newswire
Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Q32 Bio Competitors

1Athos Therapeutics
2Kyverna
3Mozart
Unlock more competitors